Section
Growth, tracking and compliance for telehealth brands that want to scale without getting burned.
On October 2, 2026 the FTC sued Lens.com over prices that allegedly doubled at checkout. A telehealth offer with membership, consult and pharmacy fees should read it as a warning and a template.
The FTC alleges Hims & Hers sent health data to Meta via pixels and customer lists. Here is the attribution firewall every telehealth clinic needs now.
An FTC complaint, a 38% revenue quarter at Hims & Hers and a second wave of FDA marketing rules landed within weeks of each other. Here is what an independent clinic should do with them before Q4.
Revenue of $753.2 million, a net loss of $86.3 million and a gross margin that fell 12 points, all in one release. A line-by-line read for independent clinics.
Beyond the data-sharing claims, the FTC's July 29, 2026 complaint targets how a telehealth company charges, renews and lets patients cancel. These are allegations. Here is what a clinic should check in its own billing flow.
Every new patient brings questions, refill requests and billing tickets. Support capacity rarely grows with them. Here is how to model support load per hundred patients before you raise the ad budget.
Manufacturer pricing deals and an oral GLP-1 changed the math clinics were built on. If you cannot win on price, here is how I would rebuild the offer around service, support and outcomes.
Involuntary churn from declined cards quietly drains subscription telehealth. This piece covers smart retries, card updaters and dunning that stays compliant.
Q1 2026 brought a fourth DEA extension, a pill launch, a Medicare telehealth reprieve and the FDA's 30 warning letters over compounded GLP-1 marketing. This desk sorts what changed for cash-pay clinics and sets priorities for Q2.
The FDA's March 2026 warning letters targeted how telehealth firms marketed compounded GLP-1s. Creator and affiliate content is marketing too. Here are claim rules, review steps and disclosures for a telehealth influencer program.
On March 3, 2026 the FDA announced 30 warning letters to telehealth companies over how they market compounded GLP-1s. Here are the patterns, from implied sameness to hidden sourcing, and what to change in your own copy.
I just watched a CEO offer to fire his Sr. Media Buyer and Marketing Director on a live Zoom call just to get access to the system behind these numbers.
I generate 5,000 to 10,000 verified leads per month for each telehealth clinic I manage. The problem isn't demand.
Showing 13 of 47